Botanical and Plant-Derived Drugs: Global Markets

NEW YORK, Dec. 19, 2012 /PRNewswire/ --Reportlinker.com announces that a new market research report is available in its catalogue:

Botanical and Plant-Derived Drugs: Global Markets

http://www.reportlinker.com/p0118047/Botanical-and-Plant-Derived-Drugs-Global-Markets.html#utm_source=prnewswire&utm_medium=pr&utm_campaign=Drug_and_Medication

INTRODUCTION

STUDY BACKGROUND

Because the use of plant-derived drugs has become so widespread, there is a great need to develop an up-to-date base of market information about these products. More than four years have passed since BCC Research published its first version of Botanical and Plant-Derived Drugs: Global Markets. This report is an update of that one. Both analyze the key growth areas in plant-derived drugs, develop quantitative market projections and discuss compliance with the requirements for the botanical category of drugs, created in 2004, with its own U.S. FDA regulations, guidelines and review process.

STUDY GOAL AND OBJECTIVES

The present study meets this need by focusing on the global market for plant-derived drugs in light of the most recent available information. In addition to looking at future and current markets for a wide variety of new, reformulated and established products, the study will analyze technological, environmental, legal/regulatory and socioeconomic developments that may influence the market for plant-derived drugs.

This report provides an analysis of the emerging botanical drug industry and markets, geographically and by therapeutic area. The future of plant-derived drugs as a whole is discussed.

More specific objectives are as follows:

See the article here:
Botanical and Plant-Derived Drugs: Global Markets